Yao, JW,
Du, YM,
Liu, JS,
Gareev, I,
Yang, G,
Kang, XH,
Wang, XX,
Beylerli, O,
Chen, X (2021) in ischemic stroke. Considering that hypoxia-inducible factor (
HIF) is a crucial regulator in hypoxic progress
Tsypysheva, I.P.,
Kovalskaya, A.V.,
Lobov, A.N.,
Makara, N.S.,
Petrova, P.R.,
Farafontova, E.I.,
Zainullina, L.F.,
Vakhitova, Yu.V.,
Zarudii, F.S. (2015) and antihypoxic properties) and in vitro (antiradical properties and ability to affect transcription factor
HIF-1
Макара, Н.С.,
Вахитова, Ю.В.,
Зарудий, Ф.С.,
Tsypysheva, I.P.,
Kovalskaya, A.V.,
Lobov, A.N.,
Petrova, P.R.,
Farafontova, E.I.,
Zainullina, L.F.,
Makara N.S.,
Vakhitova, Yu.V.,
Zarudii, F.S. (2015) and antihypoxic properties) and in vitro (antiradical properties and ability to affect transcription factor
HIF-1
LIU, Z.,
ZHANG, R.,
CHEN, X.,
YAO, P.,
YAN, T.,
LIU, W.,
YAO, J.,
ZHAO, S.,
SOKHATSKII, A.,
GAREEV, I. (2019) significantly associated with ICH, including but not limited to
HIF-1, TNF, toll-like receptor, cytokine
Gilyazova, Irina,
Ivanova, Elizaveta,
Sinelnikov, Mikhail,
Pavlov, Valentin,
Khusnutdinova, Elza,
Khusnutdinova, Elza,
Beilerli, Aferin,
Mikhaleva, Ludmila,
Liang, Yanchao (2023) -hydroxyacyl-CoA lyase 1 (HACL1), hypoxia-inducible factor 1-alpha (
HIF-1A), and nidogen 2 (NID2) genes